Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae
Margo Diricks, Sabine Petersen, Lennart Bartels, Thiên-Trí Lâm, Heike Claus, Maria Paula Bajanca-Lavado, Susanne Hauswaldt, Ricardo Stolze, Omar Jiménez Vázquez, Christian Utpatel, Stefan Niemann, Jan Rupp, Inken Wohlers, Matthias Merker · 2024
Read Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae by Margo Diricks, Sabine Petersen, Lennart Bartels, Thiên-Trí Lâm, Heike Claus, Maria Paula Bajanca-Lavado, Susanne Hauswaldt, Ricardo Stolze, Omar Jiménez Vázquez, Christian Utpatel, Stefan Niemann, Jan Rupp, Inken Wohlers, Matthias Merker (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11616347.txt.
Description
Haemophilus influenzae keeps evolving past ampicillin, sometimes without the usual enzyme to blame. Margo Diricks and co-authors re-examine the alternative route: changes in the drug's target protein, PBP3. Pooling 291 isolates, they confirm that two substitution patterns track with ampicillin resistance, while only one tracks with resistance to the stronger cefotaxime. Most unclassified isolates stayed susceptible, though one pattern proved a leaky predictor.
Genome-wide scans of two further cohorts hunt fresh determinants and trace how resistance evolves. Getting genotype and phenotype to agree matters at the bedside, where a wrong call wastes the first, best dose.
Catalog record
| CREATOR | Margo Diricks, Sabine Petersen, Lennart Bartels, Thiên-Trí Lâm, Heike Claus, Maria Paula Bajanca-Lavado, Susanne Hauswaldt, Ricardo Stolze, Omar Jiménez Vázquez, Christian Utpatel, Stefan Niemann, Jan Rupp, Inken Wohlers, Matthias Merker |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |